Uterotonics (PPH)
also: oxytocin · Syntocinon · ergometrine · carboprost · misoprostol · Syntometrine
Overview
Drugs that contract the uterus — active management of the third stage and treatment of atonic postpartum haemorrhage. The escalation order and the agent-specific contraindications are heavily tested.
Mechanism
Oxytocin binds myometrial oxytocin receptors → rhythmic contraction (first-line). Ergometrine (ergot alkaloid) causes sustained tetanic contraction via α-adrenergic/5-HT receptors. Carboprost (PGF₂α) and misoprostol (PGE₁ analogue) stimulate prostaglandin-mediated contraction.
Indications
- Active management of 3rd stage of labour
- Postpartum haemorrhage (uterine atony)
- Misoprostol/oxytocin: also miscarriage management
The agents
IV/IM
First choice for prevention + treatment of PPH.
IM/IV
AVOID in hypertension/pre-eclampsia (vasoconstriction). Often combined as Syntometrine.
deep IM, repeatable
AVOID in asthma (bronchospasm).
oral/SL/PR
Heat-stable; useful where injectables unavailable.
Adverse effects
Cautions & contraindications
Vasoconstriction → dangerous BP rise.
Prostaglandin → bronchospasm.
Interactions
- Avoid stacking vasoconstrictors with ergometrine
Monitoring & kinetics
Uterine tone, blood loss, BP, pulse
Escalation in atonic PPH: uterine massage → oxytocin → ergometrine → carboprost → misoprostol → surgical (alongside tranexamic acid).
Source: RCOG — PPH (Green-top 52) · BNF — Myometrial stimulants